388 related articles for article (PubMed ID: 25613308)
1. Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.
Lindley RI; Wardlaw JM; Whiteley WN; Cohen G; Blackwell L; Murray GD; Sandercock PA;
Stroke; 2015 Mar; 46(3):746-56. PubMed ID: 25613308
[TBL] [Abstract][Full Text] [Related]
2. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
3. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
4. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
[TBL] [Abstract][Full Text] [Related]
6. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
IST-3 collaborative group
Lancet Neurol; 2015 May; 14(5):485-96. PubMed ID: 25819484
[TBL] [Abstract][Full Text] [Related]
7. Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone.
Mocco J; Zaidat OO; von Kummer R; Yoo AJ; Gupta R; Lopes D; Frei D; Shownkeen H; Budzik R; Ajani ZA; Grossman A; Altschul D; McDougall C; Blake L; Fitzsimmons BF; Yavagal D; Terry J; Farkas J; Lee SK; Baxter B; Wiesmann M; Knauth M; Heck D; Hussain S; Chiu D; Alexander MJ; Malisch T; Kirmani J; Miskolczi L; Khatri P;
Stroke; 2016 Sep; 47(9):2331-8. PubMed ID: 27486173
[TBL] [Abstract][Full Text] [Related]
8. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
9. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
Wardlaw JM; von Kummer R; Carpenter T; Parsons M; Lindley RI; Cohen G; Murray V; Kobayashi A; Peeters A; Chappell F; Sandercock PA
Int J Stroke; 2015 Aug; 10(6):956-68. PubMed ID: 23336348
[TBL] [Abstract][Full Text] [Related]
10. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.
IST-3 collaborative group
Lancet Neurol; 2013 Aug; 12(8):768-76. PubMed ID: 23791822
[TBL] [Abstract][Full Text] [Related]
11. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
12. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
[TBL] [Abstract][Full Text] [Related]
13. Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke.
Berge E; Cohen G; Lindley RI; Sandercock P; Wardlaw JM; Sandset EC; Whiteley W
Stroke; 2015 Dec; 46(12):3362-9. PubMed ID: 26486868
[TBL] [Abstract][Full Text] [Related]
14. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Wallace AC; Gurewich V; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
Trials; 2022 Aug; 23(1):641. PubMed ID: 35945566
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic Therapy in Acute Ischemic Stroke in Patients Not Fulfilling Conventional Criteria.
Chi MS; Chan LY
Neurologist; 2017 Nov; 22(6):219-226. PubMed ID: 29095323
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Postma AA; Roosendaal SD; Krietemeijer GM; Yo LSF; de Maat MPM; Nieboer D; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
JAMA Neurol; 2023 Jul; 80(7):714-722. PubMed ID: 37213122
[TBL] [Abstract][Full Text] [Related]
17. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
[TBL] [Abstract][Full Text] [Related]
18. Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).
Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
Stroke; 2014 Dec; 45(12):3612-7. PubMed ID: 25370587
[TBL] [Abstract][Full Text] [Related]
19. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis.
Kamogawa N; Miwa K; Toyoda K; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Kitazono T; Boutitie F; Ma H; Ringleb P; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Koga M;
Stroke; 2024 Apr; 55(4):895-904. PubMed ID: 38456303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
